These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11797702)

  • 1. The judicial coordination of drug and device litigation: a review and critique.
    Wood JM
    Food Drug Law J; 1999; 54(3):325-61. PubMed ID: 11797702
    [No Abstract]   [Full Text] [Related]  

  • 2. Section 8(c) of the proposed Restatement (Third) of Torts: is it really what the doctor ordered?
    Winchester JD
    Cornell Law Rev; 1997 Mar; 82(3):644-93. PubMed ID: 10343053
    [No Abstract]   [Full Text] [Related]  

  • 3. Judicial review of FDA preemption determinations.
    Frost A
    Food Drug Law J; 1999; 54(3):367-88. PubMed ID: 11797704
    [No Abstract]   [Full Text] [Related]  

  • 4. Whistle-blowers' experiences in fraud litigation against pharmaceutical companies.
    Kesselheim AS; Studdert DM; Mello MM
    N Engl J Med; 2010 May; 362(19):1832-9. PubMed ID: 20463344
    [No Abstract]   [Full Text] [Related]  

  • 5. The human growth hormone Creutzfeld Jakob disease litigation.
    Owen R
    Med Leg J; 1997; 65 ( Pt 2)():46-64. PubMed ID: 9241994
    [No Abstract]   [Full Text] [Related]  

  • 6. Comment: litigation involving manufacturers' liability for defective medical products: judicial perspectives.
    Rosenn JX
    Am J Law Med; 1976-1977 Winter; 2(2):245-55. PubMed ID: 1052110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sandoz, Caremark agree to $20 million settlement.
    Burda D
    Mod Healthc; 1992 Sep; 22(36):5. PubMed ID: 10120359
    [No Abstract]   [Full Text] [Related]  

  • 8. Robert Stoll. Interview by Charlotte Harrison.
    Stoll R
    Nat Rev Drug Discov; 2009 Dec; 8(12):926. PubMed ID: 19949397
    [No Abstract]   [Full Text] [Related]  

  • 9. PMA primacy: synthesizing the 35 U.S.C. Section 156 patent term extension, 35 U.S.C. Section 271(e)(1) patent infringement exemption as currently applied to medical devices, and medical device preemption jurisprudence to yield a cohesive solution regarding scope of coverage.
    Flaherty JM
    Food Drug Law J; 2001; 56(3):339-49. PubMed ID: 11944643
    [No Abstract]   [Full Text] [Related]  

  • 10. Scientific evidence and the courts.
    Field TG
    Science; 1993 Dec; 262(5140):1629-30. PubMed ID: 8110275
    [No Abstract]   [Full Text] [Related]  

  • 11. POSTAL treatment.
    Lancet; 1955 Feb; 268(6858):301. PubMed ID: 13234363
    [No Abstract]   [Full Text] [Related]  

  • 12. Harmonizing legal and ethical standards for interactions between health care providers and industry.
    Gunning TG; Coleman TS
    Fertil Steril; 2005 Oct; 84(4):861-6. PubMed ID: 16213836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Judging public health research: epistemology, public health and the law.
    Wynia MK
    Am J Bioeth; 2005; 5(6):4-7. PubMed ID: 16282101
    [No Abstract]   [Full Text] [Related]  

  • 14. A pivotal medical-device case.
    Greenspan H
    N Engl J Med; 2008 Apr; 358(16):1758. PubMed ID: 18420514
    [No Abstract]   [Full Text] [Related]  

  • 15. THE USE OF EXPERIMENTAL DRUGS AND TECHNICS.
    WASMUTH CE
    Anesth Analg; 1964; 43():187-9. PubMed ID: 14164940
    [No Abstract]   [Full Text] [Related]  

  • 16. A Progress Report on Opioid Litigation.
    Ausness RC
    J Leg Med; 2020; 40(3-4):429-446. PubMed ID: 33797326
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of FDA reform.
    Trunzo J
    Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 19. A precarious balancing act--the role of the FDA as protector of public health and industry wealth.
    McCabe AR
    Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.